BSE filing, NSE: ARMANFIN. Summary written from the filing by ALFA Finder's alert engine.
Arman Financial Services Ltd: key numbers
- Share price
- ₹1,390.80
- Market cap
- ₹1,467 Cr
- Revenue (annual)
- ₹645.9 Cr
- Net profit (annual)
- ₹56.61 Cr
- P/E (TTM)
- 12.6×Sector 19.7×
- Promoter holding
- 21.93%-0.07% QoQ
- FII holding
- 2.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arman Financial Services Ltd
All →Arman Financial Services Debt & Borrowing: ₹3.58 Cr
Arman Financial Services paid quarterly interest of ₹3.58 Crore on its ₹125 Crore NCD issue. The Reg 57 certificate confirms timely debt-service fulfilment.
- Value
- ₹3.58 Cr
Arman Financial Services Credit Rating
CARE Ratings reaffirmed Arman Financial's 'CARE A-' rating on its NCDs and revised the outlook from Negative to Stable, covering its subsidiary Namra Finance too. The rated facilities total ₹42.00 crore plus a proposed ₹28.89 crore NCD issue.
Arman Financial Services Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ending September 30, 2026.
Arman Financial Services Management Change
Arman Financial Services Limited appointed Mr. Chandramouli Akkiraju as Chief Business Officer of its wholly owned subsidiary, Namra Finance Limited, effective October 16, 2026.
Arman Financial Services Promoter Selling
Promoter Himani Manakiwala sold 500 Arman Financial Services shares in the open market. The reduction trimmed his stake from 4,834 to 4,334 shares.
- Promoter stake change
- -0.01%
Arman Financial Services Debt & Borrowing: ₹0.22 Cr
Arman Financial Services Limited paid Rs. 0.22 Crore in monthly interest for its NCDs. The payment was completed on October 05, 2026, for ISIN INE109C07105.
- Value
- ₹0.22 Cr
Other board meeting date announcements
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.
Prerna Infrabuild Board Meeting Date
Prerna Infrabuild will convene its board on 04/11/2026 to consider quarter results. The meeting is proposed under Regulation 33 of the LODR.
JSL Industries Board Meeting Date
JSL Industries intimates that its Board will meet on 5 Nov 2026 to consider unaudited Q1/H1 results. The trading window closes from 1 Oct 2026 until results are public.